Document is current
Any future updates will be listed below
-
Authors
Yang, Yufan
Wadhwani, Nitin
Shimomura, Aoi
Zheng, Shuhua
Chandler, James
Lesniak, Maciej S.
Tate, Matthew C.
Sonabend, Adam M.
Kalapurakal, John
Horbinski, Craig
Lukas, Rimas
Stupp, Roger
Kumthekar, Priya
Sachdev, Sean
- License Information
-
More Information
Article History
Received: 1 April 2024
Accepted: 11 May 2024
First Online: 12 June 2024
Declarations
:
: This study was performed in line with the principles of the Declaration of Helsinki. Approval was granted by the IRB Committees of Northwestern Medicine and Lurie Children’s Hospital, approval 4/20/2022, study ID number: STU00216984.
: YY, NW, SZ, AS, JC, MSL, MCT, AMS, JK, CH, RL, RS, and SS declare no relevant financial interests. PK declares the following consulting Fees (e.g. medical advising or advisory board): Enclear Therapies, Affinia Therapeutics, Biocept, Janssen), Bioclinica, Novocure, Mirati, Servier, Roche, Telix Pharmaceuticals, PlusTherapeutics, Belay Diagnostics, Biodexa, Plus Therapeutics.
: The authors declare no competing interests.
